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SUMMARY 
 
Background: The Duke Activity Status Index (DASI) questionnaire might help incorporate self-
reported functional capacity into preoperative risk assessment. Nonetheless, prognostically 
important thresholds in DASI scores remain unclear. We conducted a nested cohort analysis of 
the Measurement of Exercise Tolerance before Surgery (METS) study to characterise the 
association of preoperative DASI scores with postoperative death or complications. 
Methods: The analysis included 1546 participants (≥40 years) at elevated cardiac risk who had 
inpatient noncardiac surgery. The primary outcome was 30-day death or myocardial injury. 
Secondary outcomes were 30-day death or myocardial infarction, in-hospital moderate-or-severe 
complications, and one-year death or new disability. Multivariable logistic regression modelling 
was used to characterise the adjusted association of preoperative DASI scores with outcomes. 
Results: The DASI score had non-linear associations with outcomes. Self-reported functional 
capacity better than a DASI score of 34 was associated with reduced odds of 30-day death or 
myocardial injury (odds ratio 0.97 per one-point increase above 34; 95% CI, 0.96 to 0.99) and 
one-year death or new disability (odds ratio 0.96 per one-point increase above 34; CI, 0.92 to 
0.99). Self-reported functional capacity worse than a DASI score of 34 was associated with 
increased odds of 30-day death or myocardial infarction (odds ratio 1.05 per one-point decrease 
below 34; CI, 1.00 to 1.09), and moderate-or-severe complications (odds ratio 1.03 per one-point 
decrease below 34; CI, 1.01 to 1.05). 
Conclusions:  A DASI score of 34 represents a threshold for identifying patients at risk for 
myocardial injury, myocardial infarction, moderate-or-severe complications and new disability. 
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INTRODUCTION 
 
Evaluation of functional capacity or cardiopulmonary fitness is considered integral to 
preoperative risk assessment for major inpatient noncardiac surgery.1 This evaluation typically 
involves a doctor making a subjective estimate of the patient’s functional capacity (i.e., 
‘subjective assessment’) following a standard preoperative interview. While subjective 
assessment is ubiquitous to clinical practice in the perioperative setting, several single-centre 
studies have raised questions about its validity as a measure of cardiopulmonary fitness and 
perioperative risk.2–4 The recent multicentre Measurement of Exercise Tolerance before Surgery 
(METS) prospective cohort study found that subjective assessment did not accurately identify 
patients who performed poorly on formal preoperative exercise testing, and did not correctly 
identify which patients are at elevated risk for postoperative morbidity.5 Instead, the Duke 
Activity Status Index (DASI),6 a 12-item self-reported questionnaire about usual physical 
activities, improved identification of patients at elevated risk for postoperative myocardial 
infarction and myocardial injury, even when used in combination with clinical risk indices such 
as the Revised Cardiac Risk Index (RCRI).7 
The DASI questionnaire (Supplemental Table 1) was developed in a sample of English-
speaking adults undergoing exercise testing in the United States,6 and has a score ranging from 0 
to 58.2, with higher scores indicating greater levels of fitness. The questionnaire is a valid 
measure of preoperative cardiopulmonary fitness,5,8,9 but there is disagreement as to how best to 
convert DASI scores to estimated metabolic equivalents.10,11 It is also unclear as to what specific 
thresholds in DASI scores define elevated perioperative risk, and whether the DASI 
questionnaire provides additional prognostic information when used in combination with 
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preoperative biomarkers such as brain natriuretic peptide (BNP) or N-terminal pro-B-type 
natriuretic peptide (NT pro-BNP).12,13 While prognostically important DASI thresholds have 
been determined in non-surgical populations,10,14,15 their generalisability to surgical patients has 
yet to be evaluated. Overall, the lack of clear DASI score cut-offs that identify patients at risk 
has limited the ability of perioperative clinicians to incorporate the questionnaire into 
preoperative assessment practice. 
We therefore conducted a nested cohort analysis of the METS study sample to 
characterise the adjusted association of preoperative DASI scores with postoperative cardiac 
complications and moderate-and-severe complications. Our primary objective was to identify 
thresholds in the DASI score that clinicians can use in routine practice to better identify patients 
at elevated risk of postoperative morbidity.  
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MATERIALS AND METHODS 
 
Design 
This report adhered to the recommendations of the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) criteria.16 We performed a nested cohort analysis of the 
METS study, which was a prospective cohort study conducted at 25 hospitals in Canada, New 
Zealand, Australia, and the United Kingdom. All participants provided written informed consent, 
and each centre obtained research ethics board approval before commencing recruitment. The 
objectives, design, methods, and primary results of the METS study have been previously 
reported.5,17 This present analysis included all eligible participants who underwent surgery, 
regardless of whether they underwent preoperative cardiopulmonary exercise testing. Thus, this 
nested cohort analysis included more participants than the primary METS study analysis,5 which 
was restricted to participants who underwent both surgery and preoperative exercise testing.  
Participants and Study Procedures 
Eligible patients had to be aged 40 years or older, scheduled for elective inpatient noncardiac 
surgery under general and/or regional anaesthesia, and deemed to have one or more risk factors 
for cardiac complications or coronary artery disease (Supplemental Table 2). Of the 1741 
individuals who consented to participate in the METS study, 1546 were included in this nested 
cohort analysis (Figure 1). Participants completed the DASI questionnaire on the date of 
recruitment and underwent blood sampling to measure serum N-terminal pro-B-type natriuretic 
peptide (NT pro-BNP) concentrations at any point between recruitment and surgery. The blood 
samples were stored at -70°C to -80°C in each study site, and then analysed at the Aberdeen 
Royal Infirmary (Aberdeen, UK) using the Siemens Vista™ immunoassay analyser (Siemens 
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Healthcare Diagnostics Ltd, Frimley, UK). Participants, healthcare providers, and outcome 
adjudicators were blinded to DASI scores and NT pro-BNP results. Additionally, 
anaesthesiologists in the preoperative evaluation clinic or operating theatre subjectively rated 
participants’ functional capacity based on their usual preoperative history. Subjectively assessed 
functional capacity was categorised as ‘poor’ (<4 metabolic equivalents), ‘moderate’ (4 to 10 
metabolic equivalents), or ‘good’ (>10 metabolic equivalents). After surgery, participants 
underwent daily electrocardiograms and blood sampling to measure troponin concentrations, 
until the third postoperative day or hospital discharge (whichever came first). Participants were 
also followed daily while in-hospital to ascertain the presence of other complications, the 
severity of which were classified as mild, moderate, severe or fatal using a modified Clavien-
Dindo scheme (Supplemental Table 3).18–20 After hospital discharge, participants were contacted 
at 30 days after surgery to ascertain vital status. 
Outcomes 
Death or myocardial injury within 30 days after surgery was selected as the primary outcome 
because it is a prognostically important postoperative cardiac complication, and it occurred with 
sufficient frequency in the METS study sample to allow unbiased multivariable logistic 
regression analyses to identify any relevant thresholds in the DASI score.21 The secondary 
outcomes were (i) death or myocardial infarction within 30 days after surgery, and (ii) moderate-
or-severe postoperative complications during the index hospitalisation. Myocardial injury was 
defined as postoperative troponin concentrations exceeding both the 99th percentile upper 
reference limit, and the threshold at which the assay coefficient of variation was 10%.22 
Myocardial infarction was diagnosed by an adjudication committee that used the Third Universal 
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Definition of Myocardial Infarction while remaining blinded to DASI and NT pro-BNP results.23 
The endpoint of moderate-or-severe complications included fatal events. 
Statistical Analyses 
Descriptive statistics were initially used to characterise the sample, both overall and across strata 
defined by the presence or absence of the study outcomes. Categorical data were compared using 
the chi-square or Fisher exact test, while continuous variables were compared using the two-
sample t-test. Multivariable logistic regression models were then used to separately evaluate the 
adjusted association of preoperative DASI scores with the primary and secondary outcomes. 
Covariates in these models were selected a priori based on prior evidence, their inclusion in 
guideline-recommended assessment algorithms (i.e., RCRI and natriuretic peptides for cardiac 
risk stratification),1,12 need to prevent model overfitting,21 and consistency with typical clinical 
practice during preoperative evaluation. For the models predicting (i) 30-day death or myocardial 
injury and (ii) 30-day death or myocardial infarction, the covariates were the validated RCRI and 
preoperative NT pro-BNP concentrations.7,12,24 As recommended by the Canadian 
Cardiovascular Society guidelines, NT pro-BNP concentration was dichotomised based on a 300 
ng/L threshold.12 In the model predicting moderate-or-severe complications, the covariates were 
age, sex, and high-risk surgery, which was defined as intra-peritoneal, intra-thoracic, or supra-
inguinal vascular procedures.7 To account for non-linear relationships between continuous 
predictor variables (i.e., DASI, age) and the study outcomes, we used restricted cubic spline plots 
to determine which transformation or categorisation – if any – was necessary. Adjusted 
associations were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Model 
discrimination was characterised by the c-index, while calibration was assessed using the 
Hosmer-Lemeshow statistic. 
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 We conducted a complete case analysis and assumed that the six participants lost to 
follow-up between hospital discharge and the 30th postoperative day remained alive during this 
follow-up window. Additionally, several sensitivity analyses were performed to evaluate the 
robustness of our primary analysis. Firstly, the analyses were repeated after multiple imputation 
to account for missing baseline data (i.e., DASI score, creatinine concentration, NT pro-BNP 
concentration) that occurred in 8% of the study sample. Twenty imputed data sets were 
calculated using chained predictive mean matching. Secondly, we used bootstrap resampling 
(1000 samples) to internally validate the multivariable logistic regression models predicting the 
three study outcomes. Thirdly, age and sex (which are not considered in current guideline-
recommended assessment algorithms)1,12 were included as additional covariates in the multiple 
variable logistic regression model predicting 30-day death or myocardial injury. Fourthly, the 
models predicting (i) 30-day death or myocardial injury and (ii) 30-day death or myocardial 
infarction were re-estimated with the RCRI as the only covariate because preoperative NT pro-
BNP concentrations are not routinely measured in many perioperative settings. 
Analyses were conducted using the R statistical language (Version 3.5.1) and Stata 
Version 14.2 (StataCorp, College Station, TX, USA). Statistical significance was defined as a 
two-tailed P<0.05 and no adjustment was made for multiple comparisons. The number of 
participants available for this substudy was determined by the sample size calculation for the 
METS study, which has been previously described.5,17 
Subset Analysis on New Postoperative Disability 
 To understand whether DASI scores also predicted functional recovery at one-year following 
surgery, we conducted a subset analysis of METS study participants in whom self-reported 
disability status was prospectively measured using the validated 12-item World Health 
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Organisation Disability Assessment Schedule (WHODAS) 2.0 instrument.25,26 As part of a pre-
specified substudy on the prognostic performance of the six-minute walk test, the WHODAS 
questionnaire was administered before surgery and subsequently at one year post-surgery.27 The 
questionnaire consists of 12 items, each of which is scored from zero to four. The sum of all item 
responses is the WHODAS Disability Score, which ranges from zero to 40 and can be expressed 
as a percentage of the maximum possible score. Moderate, severe or complete disability is 
defined as a WHODAS Disability Score exceeding 25%, and an 8% absolute difference in scores 
is considered meaningful.28 The outcome for this subset analysis was new disability or death 
within one year after surgery, where new disability was defined as postoperative WHODAS 
Disability Score that exceeded 25% and represented at an 8% or greater absolute increase from 
the preoperative measurement.27 Multivariable logistic regression modelling was used to 
estimate the adjusted association of preoperative DASI scores with new disability or death within 
one year after surgery. The covariates in the model were age, sex, preoperative moderate-severe-
or-fatal disability and high-risk surgery. We conducted a complete case analysis and used 
restricted cubic spline plots to determine the need for transformation or categorisation of 
continuous variables.  
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RESULTS 
 
Participant Characteristics 
From March 2013 to March 2016, 1741 patients were recruited into the METS study at 25 
hospitals in Canada, Australia, New Zealand, and the United Kingdom. From this overall sample, 
1546 participants were included in this substudy, of whom 1540 (99.7%) completed 30-day 
follow-up. The characteristics of the substudy cohort are presented in Table 1. Their median age 
was 65 years (IQR 57 to 62), 41% (n=629) were female, 61% (n=946) underwent major 
abdominal or pelvic procedures, 59% (n= 881) were classified as RCRI Class 2 or 3, and 13% 
(n=189) had preoperative NT pro-BNP concentrations above the high-risk threshold of 300 
ng/L.12 While only seven participants completely missed their DASI questionnaires, 64 
individuals had one or more missing responses to individual items in the questionnaire 
(Supplemental Table 1). The item with the highest frequency of missing responses (n=45) was 
the question, “Can you have sexual relations?”. Among the 1475 participants (95%) who 
responded to all questionnaire items, the median DASI score was 42.7 (interquartile range 28.7 
to 53.0). 
Postoperative Outcomes 
By 30 days after surgery, 187 (12.1%) experienced the primary outcome of death or myocardial 
injury, and 26 (1.7%) experienced the secondary outcome of death or myocardial infarction. 
During their postoperative hospitalisation, 210 (13.6%) participants experienced the secondary 
outcome of in-hospital moderate-or-severe complications. The specific types of complications 
associated with postoperative myocardial injury are presented in Supplemental Table 4. 
Prediction of 30-Day Postoperative Death or Myocardial Injury 
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In unadjusted comparisons, participants who did versus did not experience 30-day death or 
myocardial injury differed with respect to age, cardiovascular comorbidities (i.e., coronary artery 
disease, cerebrovascular disease, hypertension, atrial fibrillation), renal function, RCRI score, 
NT pro-BNP concentrations, surgery, and DASI score (Table 2). After adjustment for RCRI 
score and NT pro-BNP concentration, restricted cubic spline analyses demonstrated a non-linear 
association between the DASI score and 30-day death or myocardial injury (Supplemental Figure 
1). Based on visual inspection of this plot, there was maximum at a score of about 34. 
Approximately 32% of participants (n= 494) had DASI scores of 34 or less. In multivariable 
logistic regression analyses, the DASI score was therefore modelled as a transformed continuous 
variable where values below 34 were treated as 34. The transformed score had a linear and 
statistically significant adjusted association with 30-day death or myocardial injury (Table 3). 
Prediction of 30-Day Postoperative Death or Myocardial Infarction 
Restricted cubic spline analyses showed a non-linear unadjusted association between DASI 
scores and 30-day death or myocardial infarction (Supplemental Figure 2). Visual inspection of 
this plot suggested a minimum at a DASI score of 34. We therefore modelled the DASI score as 
a transformed continuous variable where values above 34 were treated as 34. This transformed 
DASI score had a statistically significant adjusted association with 30-day postoperative death or 
myocardial infarction (Table 4). 
Prediction of Postoperative Moderate-or-Severe Complications 
In unadjusted comparisons, participants who did versus did not experience moderate-or-severe 
complications differed with respect to sex, cardiovascular comorbidities (i.e., cerebrovascular 
disease, atrial fibrillation), NT pro-BNP concentration, surgery, but not DASI score 
(Supplemental Table 5). Restricted cubic spline analyses demonstrated a non-linear adjusted 
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association between the DASI score and postoperative complications (Supplemental Figure 3), 
with suggestion of a minimum at a DASI score of 34. In multivariable logistic regression 
analyses, the DASI score was therefore modelled as a transformed continuous variable where 
values above 34 were treated as 34. The transformed score had a linear and statistically 
significant adjusted association with moderate-or-severe complications (Supplemental Table 6). 
Sensitivity Analyses 
The adjusted association of the DASI score with the primary and secondary outcomes were 
qualitatively unchanged in sensitivity analyses that incorporated multiple imputation, bootstrap 
internal validation, and different model covariates (Supplemental Table 7). 
Subset Analysis on New Postoperative Disability 
About 35% (n=546) of patients in the primary analysis cohort completed preoperative WHODAS 
questionnaires, of whom 17% (n=95) had preoperative moderate-severe-or-complete disability 
and 95% (n=517) completed one-year follow-up (Supplemental Figure 4). The subset cohort 
(Supplemental Table 8) was qualitatively similar to the primary cohort (Table 1), aside from a 
lower prevalence of orthopaedic surgical procedures (16% in the subset cohort versus 25% in the 
primary cohort). By one-year after surgery, 14 individuals (2.6%) had died, 46 (8.4%) had new 
disability, and 60 (11.6%) had either died or developed new disability. 
  In unadjusted comparisons, participants who did versus did not experience new disability 
or death within one year after surgery differed with respect to some cardiovascular comorbidities 
(i.e., heart failure, atrial fibrillation), smoking status, and possibly preoperative disability status 
(Supplemental Table 9). Restricted cubic spline analyses suggested a non-linear adjusted 
association between the DASI score and new disability or death within one year after surgery 
(Supplemental Figure 5). Based on visual inspection of this plot, we modelled the DASI score as 
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a transformed continuous variable where values below 34 were treated as 34. The transformed 
score had a statistically significant adjusted association with new disability or death within one 
year after surgery (Supplemental Table 10). 
Post-Hoc Comparison of DASI Thresholds Versus Subjective Assessment 
Since a DASI score of 34 was a consistent prognostically important threshold across the different 
study outcomes, we performed a post-hoc analysis comparison between this DASI score 
threshold and anaesthesiologists’ subjective assessment of functional capacity. While 97% of 
participants with DASI scores of 35 or more were deemed to have moderate or good functional 
capacity, only 15% of individuals with DASI scores of 34 or lower were judged as having poor 
functional capacity (Supplemental Table 11). 
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DISCUSSION 
 
In this nested cohort analysis of the METS study, a preoperative DASI score threshold of 34 
points improved identification of patients at risk for cardiac complications, moderate-to-severe 
complications and new disability after major elective noncardiac surgery. After adjustment for 
clinical risk factors, patients with self-reported functional capacity better than a DASI score of 
34 had a lower risk of 30-day myocardial injury and one-year new disability, while individuals 
with self-reported functional capacity worse than a DASI score of 34 experienced greater risks of 
30-day myocardial infarction and in-hospital moderate-or-severe complications. This threshold 
retained prognostic importance for identifying patients at elevated cardiac risk even after 
accounting for preoperative natriuretic peptide concentrations. The findings were also consistent 
across sensitivity analyses that accounted for other preoperative risk factors, missing data and 
internal validation using bootstrap resampling. Importantly, fewer than one in five individuals 
with concerning DASI scores were subjectively assessed as having poor functional capacity by 
their responsible anaesthesiologists. Overall, the results help inform clinicians seeking practical 
approaches to better incorporate evaluation of functional capacity into usual preoperative risk 
assessment. 
Notably, when considering outcomes ascertained during the same short-term 
postoperative time-frame (i.e., ≤30 days after surgery), the adjusted association of the DASI 
score with biochemically determined (albeit prognostically important) myocardial injury differed 
qualitatively from its association with clinical events such myocardial infarction and moderate-
or-severe complications.29,30 While DASI scores below 34 demarcated a high-risk plateau for 
experiencing myocardial injury, scores above 34 demarcated a low-risk plateau for experiencing 
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myocardial infarction and moderate-or-severe complications. The basis for these differences 
warrants further research, but there are at least two possible explanations. Myocardial injury 
episodes occurring in individuals with DASI scores above 34 may have been more likely to 
represent biochemical elevations not associated with overt clinical manifestations. Additionally, 
while the risk of any myocardial injury may have reached a local maximum at DASI scores of 34 
or less, the magnitude of such injury may have been greater in individuals with DASI scores 
further below this threshold. Importantly, the practical implications for clinicians are largely 
straightforward. When using the DASI questionnaire to assess self-reported functional capacity 
during preoperative evaluation, DASI scores worse than 34 are associated with greater risks of 
myocardial injury, myocardial infarction and moderate-or-severe complications, while scores 
better than 34 are associated with lower risks of these same events. 
While it is tempting to interpret the clinical relevance of a DASI score by converting it to 
estimated metabolic equivalents, our study would caution against such an approach. Instead, 
clinicians should focus on prognostically important thresholds based on the DASI score itself. 
Prior publications highlight uncertainty as to how best to convert DASI scores to estimated 
metabolic equivalents.10,11 The METS study confirms this uncertainty: a DASI score of 34 
corresponded to a peak oxygen consumption of 17 to 18 mL/kg/min (or five metabolic 
equivalents) in the METS study sample,5 as opposed to seven metabolic equivalents based on the 
recommended conversion formula.6 Furthermore, the association of DASI scores with outcomes 
might have largely been explained by prognostically important factors aside from 
cardiopulmonary fitness (e.g., frailty),31 especially since peak oxygen consumption was 
correlated with DASI scores but not postoperative cardiac complications in the METS study.5 
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An increasing body of literature has demonstrated that preoperative BNP or NT pro-BNP 
concentrations improve the accuracy of preoperative cardiac risk assessment, even when used in 
combination with clinical risk factors.13,32 While our analysis confirms these prior findings, it 
highlights that natriuretic peptides do not substitute for evaluation of preoperative functional 
capacity. In adjusted regression models, both NT pro-BNP concentrations and DASI scores were 
independently associated with postoperative cardiac complications. Notably, NT pro-BNP 
concentrations and DASI scores have a relatively low correlation (Spearman coefficient -0.21, 
P<0.001), suggesting that they measure related but different prognostically important constructs.5 
Our study has several important limitations that should be considered. First, while the 
METS study was relatively large multicentre prospective cohort study, it was likely biased 
towards excluding very high-risk patients, largely due to the selection bias associated with the 
study’s requirement for strenuous preoperative exercise testing. Consistent with this possibility, 
the observed rate for myocardial infarction was lower than originally anticipated.5,17 Importantly, 
our findings with respect to the prognostic accuracy of DASI scores remained consistent in 
analyses focused on the more frequent, but related, outcome of prognostically important 
myocardial injury.29,33 Nonetheless, our analyses should be validated in other large surgical 
cohorts to ensure that the identified DASI score thresholds are generalisable to other 
intermediate-to-high risk surgical patients. Second, while we selected the DASI questionnaire a 
priori as the standardised instrument for assessing preoperative functional capacity in the METS 
study,17 our results do not rule out the potential prognostic role of other questionnaires that 
provide similar information.34 
Third, there remain opportunities to update and improve the DASI questionnaire. For 
example, to improve interpretability outside North America, the wording of some items (e.g., 
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question pertaining to “yard work”) could be modified,35 and the entire questionnaire could 
undergo more extensive validated translation to other languages.36 In addition, the questionnaire 
item pertaining to sexual relations may be prone to missing responses.35 In our present study, this 
specific question was responsible for the vast majority of missing responses. Further 
methodological research is needed to determine whether the item pertaining to sexual relations 
can be feasibly omitted such that overall response rates are improved while overall questionnaire 
validity is preserved. Fourth, efficacious interventions for reducing perioperative risk in patients 
with low DASI scores remain to be identified. Possible approaches that merit evaluation in future 
studies include prehabilitation (i.e., multimodal preoperative exercise training and nutritional 
supplementation), intensive perioperative hemodynamic management to minimise hypotension, 
and enhanced postoperative monitoring. Finally, this present study was a post-hoc – albeit 
methodologically robust – secondary analysis of multicentre prospective cohort study that was 
designed primarily to compare the prognostic accuracy of several different preoperative 
measures of functional capacity (i.e., physicians’ subjective assessment, DASI scores, 
cardiopulmonary exercise testing, natriuretic peptides).5,17 Thus, further studies are needed to 
confirm the findings of our present study. 
Conclusions 
In this nested cohort analysis of a multicentre prospective cohort study, preoperative scores on 
the 12-item DASI questionnaire were predictive of 30-day death or myocardial injury, 30-day 
death or myocardial infarction, in-hospital moderate-or-severe complications and one-year new 
disability or death after major inpatient noncardiac surgery. In general, patients with DASI 
scores lower than 34 points experienced elevated risks of these complications, even after 
accounting for their clinical risk factors. These findings suggest that incorporation of DASI 
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scores into preoperative evaluation will help improve the accurate identification of intermediate-
to-high risk patients who warrant modifications in perioperative care or recruitment into targeted 
clinical research studies. 
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FIGURE LEGENDS 
 
Figure 1: Participant screening, recruitment and follow-up in primary nested cohort analysis of 
METS study cohort 
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Table 1: Characteristics of study sample 
 
 
Overall 
Cohort 
(N = 1546) 
Missing 
Data 
(n) 
Demographics   
Age, years   
Median (IQR) 65 (57 – 72)  
Mean (SD) 64 (10)  
Female sex 629 (41%)  
Preoperative Characteristics   
Coronary artery disease 210 (14%)  
Heart failure 26 (2%)  
Cerebrovascular disease 64 (4%)  
Peripheral arterial disease 49 (3%)  
Diabetes mellitus 301 (19%)  
Hypertension 865 (56%)  
Atrial fibrillation 58 (4%)  
Current or recent smoker* 255 (16%)  
Obstructive lung disease† 200 (13%)  
Subjective assessment of functional capacity  52 
Poor (<4 metabolic equivalents) 109 (7%)  
Moderate (4 to 10 metabolic equivalents) 848 (57%)  
Good (>10 metabolic equivalents) 537 (36%)  
Duke Activity Status Index, points  71 
Median (IQR) 42.7 (28.7 – 53.0)  
Mean (SD) 40.5 (15.2)  
Preoperative renal function‡  58 
     eGFR ≥60 mL/min/1·73 m2 1311 (88%)  
     eGFR 30 to 59 mL/min/1·73 m2 144 (9%)  
     eGFR <30 mL/min/1·73 m2 or dialysis  33 (2%)  
Preoperative natriuretic peptide concentration  61 
     NT pro-BNP <100 ng/L  826 (56%)  
     NT pro-BNP 100 ng/L to <300 ng/L  470 (32%)  
     NT pro-BNP ng/L ≥300 ng/L  189 (13%)  
Revised Cardiac Risk Index§  58 
     Class I 557 (37%)  
     Class 2 677 (46%)  
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     Class 3 204 (14%)  
     Class 4 50 (3%)  
Operative Characteristics   
Procedure type – no. (%)   
     Vascular 29 (2%)  
     Intra-thoracic 35 (2%)  
     Intra-peritoneal or retro-peritoneal 489 (32%)  
     Urologic or gynaecologic 457 (30%)  
     Head-and-neck 109 (7%)  
     Orthopaedic 388 (25%)  
     Other 39 (3%)  
Abbreviations: eGFR, estimated glomerular filtration rate 
 
* Current smoker or quit within previous one year 
† Prior diagnosis of asthma, reactive airways disease, chronic obstructive lung disease, chronic 
bronchitis, or emphysema 
‡ Estimated glomerular filtration rate was calculated using the preoperative serum creatinine 
concentration and Chronic Kidney Disease Epidemiology Collaboration equation.  
§ Revised Cardiac Risk Index scores were calculated using a modified definition of diabetes 
mellitus (i.e., any known diagnosis, versus requirement for insulin). All missing Revised Cardiac 
Risk Index scores were related to missing preoperative creatinine concentration data. 
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Table 2: Bivariate comparisons between patients who did versus did not suffer 30-day 
postoperative death or myocardial injury 
 
 
 Alive at 30 
Days Without 
Myocardial 
Injury 
(n=1359) 
30-Day 
Death or 
Myocardial 
Injury 
(n = 187)   
P-Value 
Demographics    
Age – years, mean (SD) 63 (10) 70 (10) <0.001 
Female sex – no. (%) 554 (41%) 75 (40%) 0.86 
Preoperative Characteristics     
Coronary artery disease 162 (12%) 48 (26%) <0.001 
Heart failure 21 (2%) 5 (3%) 0.23 
Cerebrovascular disease 50 (4%) 14 (7%) 0.01 
Peripheral arterial disease 40 (3%) 9 (5%) 0.17 
Diabetes mellitus 258 (19%) 43 (23%) 0.19 
Hypertension 743 (55%) 122 (65%) 0.006 
Atrial fibrillation 46 (3%) 12 (6%) 0.04 
Current or recent smoker* 231 (17%) 24 (13%) 0.15 
Obstructive lung disease† 182 (13%) 18 (10%) 0.15 
Duke Activity Status Index, points, mean (SD) 41 (15) 36 (15) <0.001 
Preoperative renal function‡    
     eGFR ≥60 mL/min/1·73 m2 1165 (89%) 146 (80%) 0.002 
     eGFR 30 to 59 mL/min/1·73 m2 114 (8%) 30 (16%)  
     eGFR <30 mL/min/1·73 m2 or dialysis 27 (2%) 6 (3%)  
Preoperative natriuretic peptide concentration    
     NT pro-BNP <100 ng/L 763 (59%) 63 (35%) <0.001 
     NT pro-BNP 100 ng/L to <300 ng/L 403 (31%) 67 (37%)  
     NT pro-BNP ng/L ≥300 ng/L 138 (11%) 51 (28%)  
Revised Cardiac Risk Index§    
     Class I 501 (38%) 56 (30%) <0.001 
     Class 2 602 (46%) 75 (41%)  
     Class 3 166 (13%) 38 (21%)  
     Class 4 37 (3%) 13 (7%)  
Operative Characteristics    
Procedure type – no. (%)    
     Vascular 20 (2%) 9 (5%) <0.001 
     Intra-thoracic 28 (2%) 7 (4%)  
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     Intra-peritoneal or retro-peritoneal 435 (32%) 54 (29%)  
     Urologic or gynaecologic 415 (31%) 42 (22%)  
     Head-and-neck 102 (8%) 7 (4%)  
     Orthopaedic 320 (24%) 68 (37%)  
     Other 39 (3%) 0 (0%)  
Abbreviations: eGFR, estimated glomerular filtration rate 
 
* Current smoker or quit within previous one year 
† Prior diagnosis of asthma, reactive airways disease, chronic obstructive lung disease, chronic 
bronchitis, or emphysema 
‡ Estimated glomerular filtration rate was calculated using the preoperative serum creatinine 
concentration and Chronic Kidney Disease Epidemiology Collaboration equation.  
§ Revised Cardiac Risk Index scores were calculated using a modified definition of diabetes 
mellitus (i.e., any prior diagnosis of diabetes mellitus, as opposed to requirement for insulin 
therapy). All missing Revised Cardiac Risk Index scores were related to missing preoperative 
creatinine concentration data. 
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Table 3: Adjusted association of DASI score and other clinical risk factors with 30-day 
postoperative death or myocardial injury* 
 
Preoperative Risk Factor 
Odds Ratio (95% CI) for 
30-Day Death or 
Myocardial Injury 
P-
Value 
DASI score   
Expressed as transformed continuous variable   
Per 1-point increase above 34 points 0.97 (0.96 to 0.99) 0.002 
Thresholds extrapolated from transformed variable    
≤34 points 1.97 (1.28 to 3.04)  
35 points 1.92 (1.26 to 2.90)  
40 points 1.67 (1.20 to 2.31)  
45 points 1.44 (1.14 to 1.83)  
50 points 1.26 (1.09 to 1.46)  
55 points 1.09 (1.03 to 1.16)  
58.2 points (maximum score) Reference  
Revised Cardiac Risk Index†   
Class 1  Reference 0.07 
Class 2 1.08 (0.74 to 1.59)  
Class 3 1.65 (1.02 to 2.68)  
Class 4 2.05 (0.97 to 4.35)  
Preoperative NT pro-BNP concentration   
<300 ng/L Reference  
≥300 ng/L 2.43 (1.60 to 3.69) <0.001 
 
* Model was fit using 1417 observations with complete data. The multivariable regression model 
had a c-index of 0.66 and Hosmer-Lemeshow goodness-of-fit statistic p-value of 0.12 
† Revised Cardiac Risk Index scores were calculated using a modified definition of diabetes 
mellitus (i.e., any known diagnosis, versus requirement for insulin). All missing Revised Cardiac 
Risk Index scores were related to missing preoperative creatinine concentration data. 
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Table 4: Adjusted association of DASI score and other clinical risk factors with 30-day 
postoperative death or myocardial infarction* 
 
Preoperative Risk Factor 
Odds Ratio (95% CI) for 
30-Day Death or 
Myocardial Infarction 
P-
Value 
DASI score   
Expressed as transformed continuous variable   
Per 1-point decrease below 34 points 1.05 (1.00 to 1.09) 0.04 
Thresholds extrapolated from transformed variable   
5 points 3.63 (1.05 to 12.61)  
10 points 2.90 (1.04 to 8.15)  
15 points 2.32 (1.03 to 5.26)  
20 points 1.86 (1.02 to 3.40)  
25 points 1.49 (1.01 to 2.20)  
30 points 1.19 (1.01 to 1.42)  
≥34 points Reference  
Revised Cardiac Risk Index†   
Class 1 or 2 Reference  
Class 3 or 4 2.22 (0.93 to 4.35) 0.07 
Preoperative NT pro-BNP concentration   
<300 ng/L Reference  
≥300 ng/L 1.55 (0.58 to 4.19) 0.38 
 
* Model was fit using 1417 observations with complete data. The multivariable regression model 
had a c-index of 0.67 and Hosmer-Lemeshow goodness-of-fit statistic p-value of 0.66 
† Revised Cardiac Risk Index scores were calculated using a modified definition of diabetes 
mellitus (i.e., any known diagnosis, versus requirement for insulin). All missing Revised Cardiac 
Risk Index scores were related to missing preoperative creatinine concentration data. 
 
